Elevance Health Inc. ELV NYSE

Elevance Health Inc. (ELV) generated $4.29B in operating cash flow for fiscal year 2025. After capital expenditures of $1.12B, free cash flow was $3.17B.

Free cash flow margin was 1.6% of revenue. Cash conversion ratio was 0.76x, suggesting some earnings are non-cash.

The company returned $1.53B in dividends and $2.61B in share buybacks to shareholders during the period.

Criteria supported by this page:

• HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (63/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
• INCOME (30/100) — Cash conversion ratio was 0.76x suggests some earnings are non-cash items

Overall SharesGrow Score: 62/100 with 3/7 criteria passed.